A Tomato-Based, Lycopene-Containing Intervention for Androgen-Independent Prostate Cancer: Results of a Phase II Study from The North Central Cancer Treatment Group

Urology

Volumn 69, Issue 2, 2007, Pages 289-294

  Jatoi, Aminah ^a   Burch, Patrick ^a   Hillman, David ^a   Vanyo, Joanne M ^b   Dakhil, Shaker ^c   Nikcevich, Daniel ^d   Rowland, Kendrith ^e   Morton, Roscoe ^f   Flynn, Patrick J ^g   Young, Charles ^a   Tan, Winston ^h  

^a MAYO CLINIC   (United States)

^b Toledo Community Hospital Oncology Program CCOP   (United States)

^c Witchita Community Clinical Oncology Program   (United States)

^d Duluth Community Clinical Oncology Program   (United States)

^e Carle Cancer Center Community Clinical Oncology Program   (United States)

^f Iowa Oncology Research Association Community Clinical Oncology Program   (United States)

^g Metro Minnesota Community Clinical Oncology Program   (United States)

^h MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; LYCOPENE; PROSTATE SPECIFIC ANTIGEN;

ABDOMINAL DISTENSION; ADULT; AGED; ALTERNATIVE MEDICINE; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; BACKACHE; BLADDER OBSTRUCTION; BLEEDING; CANCER PATIENT; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; DIARRHEA; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; FLATULENCE; HUMAN; HYPOALBUMINEMIA; HYPOCALCEMIA; HYPOTENSION; LEUKOPENIA; MALE; MOTIVATION; MUSCULOSKELETAL DISEASE; NAUSEA; PHASE 2 CLINICAL TRIAL; POLYURIA; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; TOMATO; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BLEEDING; VOMITING;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANDROGENS; ANTICARCINOGENIC AGENTS; BIOPSY, NEEDLE; CAROTENOIDS; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; FOLLOW-UP STUDIES; HUMANS; LYCOPERSICON ESCULENTUM; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; PATIENT SELECTION; PROBABILITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33847049097     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.10.019     Document Type: Article

References (13)

1. Cowley G. Now, "integrative" care (2002) Newsweek, December 2
2. Yoshimura K., Ueda N., Ichioka K., et al. Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Support Care Cancer 13 (2005) 685-690
3. Lee M.M., Chang J.S., Jacobs B., et al. Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Pub Health 92 (2002) 1606-1609
4. Giovannucci E. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J Nutr 135 (2005) 2030S-2031S
5. Kucuk O., Sarkar F.H., Sakr W., et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10 (2001) 861-868
6. Chen L., Stacewicz-Sapuntzakis M., Duncan C., et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 93 (2001) 1872-1879
7. Matlaga B.R., Hall C., Stindt D., et al. Response of hormone refractory prostate cancer to lycopene. J Urol 166 (2001) 613
8. Ansari M.S., and Gupta N.P. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol Oncol 22 (2004) 415-420
9. Bubley G.J., Carducci M., Dahut W., et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate Specific Antigen Working Group. J Clin Oncol 17 (1999) 3461-3467
10. Nguyen M.L., and Schwartz S.J. Lycopene stability during food processing. Proc Soc Exp Biol Med 218 (1998) 101-105
11. Therasse P., Arbuck S.G., Eisnehauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
12. Kaplan E., and Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 53 (1958) 457-481
13. Bowen P.E. Selection of surrogate endpoint markers to evaluate the efficacy of lycopene/tomatoes for the prevention/progression of prostate cancer. J Nutr 135 (2005) 2068S-2070S